Paracetamol KRKA 1000 mg tabletti Finland - Fins - Fimea (Suomen lääkevirasto)

paracetamol krka 1000 mg tabletti

krka, d.d., novo mesto - paracetamol - tabletti - 1000 mg - parasetamoli

Comboval 10 mg/ml + 3 mg/ml infuusioneste, liuos Finland - Fins - Fimea (Suomen lääkevirasto)

comboval 10 mg/ml + 3 mg/ml infuusioneste, liuos

laboratoire aguettant - paracetamol, ibuprofen sodium dihydrate - infuusioneste, liuos - 10 mg/ml + 3 mg/ml - parasetamoli

Actraphane Europese Unie - Fins - EMA (European Medicines Agency)

actraphane

novo nordisk a/s - insulin human - diabetes mellitus - diabeetilla käytettävät lääkkeet - diabetes mellituksen hoito.

Mixtard Europese Unie - Fins - EMA (European Medicines Agency)

mixtard

novo nordisk a/s - insulin human - diabetes mellitus - diabeetilla käytettävät lääkkeet - diabetes mellituksen hoito.

Revolade Europese Unie - Fins - EMA (European Medicines Agency)

revolade

novartis europharm limited - eltrombopag - purpura, trombosytopeeninen, idiopaattinen - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Panadol 24 mg/ml oraalisuspensio Finland - Fins - Fimea (Suomen lääkevirasto)

panadol 24 mg/ml oraalisuspensio

haleon denmark aps - paracetamol - oraalisuspensio - 24 mg/ml - parasetamoli

PANADOL 500 mg peräpuikko Finland - Fins - Fimea (Suomen lääkevirasto)

panadol 500 mg peräpuikko

glaxosmithkline consumer healthcare a/s - paracetamolum - peräpuikko - 500 mg - parasetamoli

PANADOL 500 mg tabletti Finland - Fins - Fimea (Suomen lääkevirasto)

panadol 500 mg tabletti

sterling-midy - paracetamolum - tabletti - 500 mg - parasetamoli

TREXAN 2.5 mg/ml injektioneste, liuos Finland - Fins - Fimea (Suomen lääkevirasto)

trexan 2.5 mg/ml injektioneste, liuos

orion corporation - methotrexatum - injektioneste, liuos - 2.5 mg/ml - metotreksaatti

TREXAN 25 mg/ml injektioneste, liuos Finland - Fins - Fimea (Suomen lääkevirasto)

trexan 25 mg/ml injektioneste, liuos

orion corporation - methotrexatum - injektioneste, liuos - 25 mg/ml - metotreksaatti